MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes

por Veitch, Shawn, Njock, Makon-Sébastien, Chandy, Mark, Siraj, M. Ahsan, Chi, Lijun, Mak, HaoQi, Yu, Kai, Rathnakumar, Kumaragurubaran, Perez-Romero, Carmina Anjelica, Chen, Zhiqi, Alibhai, Faisal J., Gustafson, Dakota, Raju, Sneha, Wu, Ruilin, Zarrin Khat, Dorrin, Wang, Yaxu, Caballero, Amalia, Meagher, Patrick, Lau, Edward, Pepic, Lejla, Cheng, Henry S., Galant, Natalie J., Howe, Kathryn L., Li, Ren-Ke, Connelly, Kim A., Husain, Mansoor, Delgado-Olguin, Paul, Fish, Jason E.
Publicado 2022